Business Segments Catalent, Inc. Berne S.E.

Stocks

Delayed Berne S.E. Other stock markets			5-day change	1st Jan Change
- ^CHF	-.--%		-.--%	-

07-07	Nanoscope Therapeutics Expands Partnership With Catalent to Support Late-Phase Development and Commercial Supply of MCO-010	CI
06-16	Catalent Launches Qai Enterprise AI Tool for Quality Management System Processes	CI

Breakdown by Business Segment (USD)

Fiscal Period: June	2020	2021	2022	2023	2024
Pharmaceutical Products
Pharma and Consumer Health	-	-	-	2.29B	2.43B
Total Assets	-	-	-	4.87B	4.64B
CAPEX	-	-	-	-214M	-164M
EBITDA	-	-	-	548M	597M
Softgel and Oral Technologies	1.06B	1.01B	1.25B	-	-
Total Assets	1.5B	1.6B	2.68B	-	-
CAPEX	-53.6M	-61M	-109M	-	-
EBITDA	256M	237M	292M	-	-
D&A	46.1M	-	-	-	-
Oral Drug Delivery	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Clinical Supply Services	345M	391M	400M	-	-
Total Assets	451M	483M	700M	-	-
CAPEX	-10M	-26M	-17M	-	-
EBITDA	91.2M	108M	110M	-	-
D&A	18.8M	-	-	-	-
Softgel Technologies	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Protein and Genome Sequence Products
Biologics	1.02B	1.93B	2.55B	1.98B	1.95B
Total Assets	3.78B	4.97B	5.73B	5.75B	5.33B
CAPEX	-330M	-516M	-453M	-346M	-171M
EBITDA	238M	608M	798M	277M	272M
D&A	112M	-	-	-	-
Corporate	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-17.2M	-19M	-30M	-34M	-16M
EBITDA	-	-	-	-	-
D&A	21.7M	-	-	-	-
Total Assets	801M	783M	382M	164M	-216M
Inter-Segment Revenue Elimination	-10.2M	-19M	-17M	-2M	-2M
EBITDA	-42.2M	-87M	-119M	-125M	-
EBITDA	-48.1M	-51M	-54M	-35M	-68M
EBITDA	-	-	-	-	-
EBITDA	-	-	-	-	-155M
Biological Products
Biologics and Specialty Drug Delivery	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Drug Delivery Technologies
Oral and Specialty Delivery	676M	686M	650M	-	-
Total Assets	1.25B	1.27B	1.01B	-	-
CAPEX	-55.4M	-64M	-57M	-	-
EBITDA	201M	160M	192M	-	-
D&A	55.1M	-	-	-	-
Drug Delivery Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-

Geographical breakdown of sales (USD)

Fiscal Period: June	2020	2021	2022	2023	2024
United States	1.82B	2.46B	3.11B	2.77B	2.82B
Total Assets	1.4B	1.87B	2.27B	2.76B	2.62B
Europe	976M	1.34B	1.51B	1.26B	1.36B
Total Assets	404M	541M	747M	765M	828M
Other	376M	288M	327M	355M	356M
Total Assets	100M	116M	113M	159M	190M
Elimination of Revenue Attributable to Multiple Locations	-79.8M	-95M	-115M	-117M	-157M